Medsafe

Following a disastrous period which has seen Kiwi company Promisia Integrative prosecuted by the Ministry of Health, its flagship product banned in Australia, and falling sales, the company has revealed it’s reinventing itself

The body representing New Zealand’s fledgling medicinal cannabis industry is welcoming the long-awaited regulations that will govern the sector

Several “detox” and diet teas have been revealed to contain sennosides, a pharmacy-only medicine, and pulled from the shelves, following a Consumer NZ investigation

The Medicines Classification Committee has determined reclassifying all codeine-containing medicines to prescription-only is justified

The migraine treatment Cafergot (AFT Pharmaceuticals) will no longer be approved for use in New Zealand from May next year

Medsafe has issued a warning after a patient taking the anticoagulant dabigatran experienced vasculitis

The migraine treatment Cafergot will no longer be approved for use in New Zealand from May next year

All indigestion medicines containing ranitidine have been recalled or had their supply halted after a carcinogenic impurity was identified in it

Two pharmaceutical companies have voluntarily recalled the ranitidine-containing indigestion medication Zantac after a potentially carcinogenic impurity was identified in it last month

Emotions ran high at the Health Select Committee yesterday, with MPs grilling Medsafe and the Ministry of Health on a brand change to a generic antidepressant